Literature DB >> 2499636

Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates.

J M Peeters1, T G Hazendonk, E C Beuvery, G I Tesser.   

Abstract

Peptide-carrier conjugates are widely used to raise antipeptide antibodies. In a model system using angiotensin and tetanus toxoid as the peptide and the carrier protein respectively, four cross-linking reagents were employed to study their effect on the immunogenicity of the conjugates. Optimization of the conjugation method for these heterobifunctional reagents, all succinimidyl active esters, resulted in well-defined conjugates of predictable composition. ELISA assays were performed to compare the antigenicity and the immunogenicity of the conjugates. The antipeptide antibody titres were of the order of 2 X 10(4)-2 X 10(5). The anti-carrier antibody titres were high, in spite of the modification of the protein. Three of the four coupling reagents used for conjugation were of the 'maleimide' type: succinimidyl 6-(N-maleimido)-n-hexanoate (MHS), succinimidyl 4-(N-maleimidomethyl)-cyclohexane-1-carboxylate (SMCC) and succinimidyl m-maleimidobenzoate (MBS). One coupling reagent contained an activated disulphide: succinimidyl 3-(2-pyridyldithio)propionate (SPDP). The constrained linkers originating from SMCC and MBS induced very high linker-specific antibody levels. The more flexible non-aromatic linkers originating from MHS and SPDP showed almost no reactivity. For this reason and since the thioether linkage is more stable than the disulphide bond, we recommend MHS as the crosslinking reagent of choice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499636     DOI: 10.1016/0022-1759(89)90298-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  21 in total

1.  Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.

Authors:  Andrew D Cox; Frank St Michael; Dhamodharan Neelamegan; Suzanne Lacelle; Chantelle M Cairns; Marzia M Giuliani; Alessia Biolchi; J Claire Hoe; E Richard Moxon; James C Richards
Journal:  Glycoconj J       Date:  2010-10-05       Impact factor: 2.916

Review 2.  Recent advances in the molecular design of synthetic vaccines.

Authors:  Lyn H Jones
Journal:  Nat Chem       Date:  2015-12       Impact factor: 24.427

3.  Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines.

Authors:  Kamran Kafi; David J Betting; Reiko E Yamada; Michael Bacica; Kristopher K Steward; John M Timmerman
Journal:  Mol Immunol       Date:  2008-11-28       Impact factor: 4.407

4.  Further characterization of the PW peptide family that inhibits neuron differentiation in Hydra.

Authors:  Toshio Takahashi; Osamu Koizumi; Eisuke Hayakawa; Sumiko Minobe; Rinako Suetsugu; Yoshitaka Kobayakawa; Thomas C G Bosch; Charles N David; Toshitaka Fujisawa
Journal:  Dev Genes Evol       Date:  2009-01-30       Impact factor: 0.900

5.  Vaccination against weight gain.

Authors:  Eric P Zorrilla; Shinichi Iwasaki; Jason A Moss; Jason Chang; Jonathan Otsuji; Koki Inoue; Michael M Meijler; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

6.  The sequence A alpha-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies.

Authors:  W J Schielen; M Voskuilen; G I Tesser; W Nieuwenhuizen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.

Authors:  Nienke E van Houten; Kevin A Henry; George P Smith; Jamie K Scott
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

8.  Tolerant anti-insulin B cells are effective APCs.

Authors:  Peggy L Kendall; James B Case; Allison M Sullivan; Jeff S Holderness; K Sam Wells; Edwin Liu; James W Thomas
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

9.  A fully synthetic and biochemically validated phosphatidyl inositol-3-phosphate hapten via asymmetric synthesis and native chemical ligation.

Authors:  Brent D Chandler; Anne L Burkhardt; Klaudia Foley; Courtney Cullis; Denise Driscoll; Natalie Roy D'Amore; Scott J Miller
Journal:  J Am Chem Soc       Date:  2013-12-17       Impact factor: 15.419

10.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.